Share listings and depositary receipts

London Stock Exchange

The Company's primary listing and ordinary shares are admitted to the Official List of the London Stock Exchange. Hikma's relevant listing is under:
EPIC: HIK, SEDOL: B0LCW08 GB, ISIN: GB00B0LCW083. Further information on this market, its trading systems and current trading in Hikma's shares can be found on the London Stock Exchange website which can be accessed at: www.londonstockexchange.com

ADR programme

Hikma Pharmaceuticals PLC has an American Depositary Receipt ("ADR") programme for which Bank of New York Mellon acts as Depositary. One ADR equates to 2 Hikma ordinary shares. ADRs are traded as a Level 1 Over-The-Counter ("OTC") programme under the symbol HKMPY. Enquiries should be made to:

BNY Mellon Shareowner Services
PO Box 358516
Pittsburgh, PA 15252-8516

Telephone: +1 201 680 6825
Telephone: +1 888 BNY ADRS (toll-free within the US)

Email: shrrelations@bnymellon.com

GDR information

The Company also has listed Global Depositary Receipts (“GDRs”) on NASDAQ Dubai for which Citibank acts as Depositary. They are listed under EPIC – HIK and ISIN – US4312882081. Enquiries should be made to:

Citibank N.A. GDR Depositary Bank
Citibank Shareholder Services
Address: P.O. Box 43077, Providence,
Rhode Island 02940-3077, US

Telephone: 1 877 CITI ADR (toll-free)
Telephone: 1 781 575 4555 (out of US)

Email: citibank@shareholders-online.com

Further information on NASDAQ Dubai, its trading systems and current trading in Hikma Pharmaceuticals PLC GDRs can be found on the website www.nasdaqdubai.com